Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Pashna N. Munshi"'
Autor:
Michael R. Cook, C. Scott Dorris, Kepher H. Makambi, Yutong Luo, Pashna N. Munshi, Michelle Donato, Scott Rowley, Ayman Saad, Andre Goy, Kieron Dunleavy, Alaa Ali
Publikováno v:
Blood Advances. 7:32-39
Relapsed/refractory primary central nervous system lymphoma (PCNSL) and secondary central nervous system lymphoma (SCNSL) are associated with short survival and represent an unmet need, requiring novel effective strategies. Anti-CD19 chimeric antigen
Autor:
Kwang Woo Ahn, Peiman Hematti, Mohamed A. Kharfan-Dabaja, Pashna N. Munshi, Mazyar Shadman, Siddhartha Ganguly, Farhad Khimani, Marcelo C. Pasquini, Alex F. Herrera, Jonathon B. Cohen, Mehdi Hamadani, Yue Chen, Jean Yared, Cameron J. Turtle, Patrick M. Reagan, Frederick L. Locke, Craig S. Sauter, Reid W. Merryman, Amer Beitinjaneh, Nausheen Ahmed
Publikováno v:
Blood. 139:1330-1339
The relative efficacy of autologous hematopoietic cell transplant (auto-HCT) vs chimeric antigen receptor T-cell (CAR-T) therapy in patients with diffuse large B-cell lymphoma (DLBCL) who achieve a partial remission (PR) after salvage chemotherapy is
Autor:
Pashna N. Munshi, Jane Fall-Dickson, Joanne Assarsson, Samira Beheshtian, Tania Lobo, Anthony Chicaiza, Felice Yang, Michele L. Donato, Sukhdeep Kaur, Hyung Suh, Alene Mathurin, Shuqi Wang, Jaeil Ahn, Kristi Graves
Publikováno v:
Transplantation and Cellular Therapy. 29:S361-S362
Autor:
Omar Davila, Muzaffar H. Qazilbash, Parameswaran Hari, Nina Shah, Pashna N. Munshi, Shaji Kumar, David H. Vesole, Andrew St. Martin, Anita D'Souza
Publikováno v:
Cancer, vol 127, iss 22
BACKGROUND Consolidative autologous hematopoietic stem cell transplantation (AHCT) is commonly used for patients with multiple myeloma (MM). We studied AHCT use and outcomes in patients with MM ≥75 years old. METHODS Patients with MM ≥75 years ol
Autor:
Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew L. Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph Rosenblatt, Jiali Yan, Qinghua Song, Weixin Peng, Christine Lui, Jacob Wulf, Rhine R. Shen, Soumya Poddar, Harry Miao, Sara Beygi, Caron A. Jacobson
Publikováno v:
Transplantation and Cellular Therapy. 29:S374
Autor:
Pashna N. Munshi, Yue Chen, Kwang W. Ahn, Farrukh T. Awan, Amanda Cashen, Geoffrey Shouse, Mazyar Shadman, Paul Shaughnessy, Joanna Zurko, Frederick L. Locke, Aaron M. Goodman, Jose C. Villaboas Bisneto, Craig Sauter, Mohamad A. Kharfan-Dabaja, Gabrielle Meyers, Samantha Jaglowski, Alex Herrera, Mehdi Hamadani
Publikováno v:
Transplantation and cellular therapy. 28(8)
Data for outcomes after autologous hematopoietic cell transplantation (auto-HCT) in diffuse large B-cell lymphoma (DLBCL) patients ≥70 years are limited. Auto-HCT is feasible in older DLBCL patients. Using the Center for International Blood and Mar
Autor:
Miguel Angel Diaz, David Szwajcer, Lynette C.Y. Chee, Claudio G. Brunstein, Mary Eapen, Nina Orfali, David A. Rizzieri, Timothy Prestidge, Ian K. McNiece, Olle Ringdén, Melhem Solh, Pashna N. Munshi, Michael R. Grunwald, Sachiko Seo, Hillard M. Lazarus, Muhammad Bilal Abid, Mei-Jie Zhang, Filippo Milano, Jean A. Yared, Peiman Hematti, Jaap Jan Boelens, Mariam Allbee-Johnson, Marcie L. Riches, Scott D. Solomon, Andrew S. Artz, Jingmei Hsu, Koen van Besien
Publikováno v:
Transplant Cell Ther
The in vivo depletion of recipient and donor T lymphocytes using antithymocyte globulin (ATG; Thymoglobulin) is widely adopted in allogeneic hematopoietic stem cell transplantation (HCT) to reduce the incidence of both graft failure and graft-versus-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac04ae666f791dd92ad2942b1a5b227
https://europepmc.org/articles/PMC8671234/
https://europepmc.org/articles/PMC8671234/
Autor:
Carmelo Carlo-Stella, Kami J. Maddocks, Sairah Ahmed, Manali Kamdar, Mazyar Shadman, Mahmoud Aljurf, Tycel Phillips, Brad S. Kahl, David J. Inwards, Martin Dreyling, Frederick L. Locke, Mohamed A. Kharfan-Dabaja, Nilanjan Ghosh, Amanda F. Cashen, Michael Wang, Jonathan W. Friedberg, Anna Sureda, Mats Jerkeman, Stephen P. Robinson, Matthew A. Lunning, Timothy S. Fenske, Jonathon B. Cohen, John P. Leonard, Craig S. Sauter, Alex F. Herrera, Pashna N. Munshi, Vaishalee P. Kenkre, Bipin N. Savani, Peter Dreger, Veronika Bachanova, Mehdi Hamadani, Ambuj Kumar, Sonali M. Smith, Brian T. Hill
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Transplantation and cellular therapy
Universidad de Barcelona
Transplantation and cellular therapy
Autologous (auto-) and allogeneic (allo-) hematopoietic cell transplantation (HCT) are accepted treatment modalities in contemporary treatment algorithms for mantle cell lymphoma (MCL). Chimeric antigen receptor (CAR) T cell therapy recently received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7add1b94fdc73da4cadeabe5841d900
http://hdl.handle.net/2445/180086
http://hdl.handle.net/2445/180086
Autor:
Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew L. Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph Rosenblatt, Marika Sherman, Jinghui Dong, Alessandro Giovanetti, Yin Yang, Christine Lui, Zahid Bashir, A. Scott Jung, Caron A. Jacobson
Publikováno v:
Transplantation and Cellular Therapy. 28:S64-S65
Autor:
Pashna N. Munshi, Jane Fall-Dickson, Joanne Assarsson, Samira Beheshtian, Tania Lobo, Anthony Chicaiza, Felice Yang, Michele L. Donato, Sukhdeep Kaur, Hyung Suh, Scott D. Rowley, Kristi Graves
Publikováno v:
Transplantation and Cellular Therapy. 28:S400-S401